Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACCESS: CCX168 in ESRD Patients with aHUS
NCT02464891Phase 2Terminated
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- Jun 2015
- Primary completion
- Jul 2017
- Countries
- 1
01
Overview
A Phase 2 trial of avacopan in atypical hemolytic uremic syndrome (aHUS), sponsored by Mario Negri Institute for Pharmacological Research. Started Jun 2015; status: terminated.
02
Drugs
avacopan
03
Conditions
atypical hemolytic uremic syndrome (aHUS)
Beyond the preview
Go deeper on NCT02464891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02464891.